Pharmacogenomics

Pharmacogenomics is the study of how genes affect a person’s response to drugs. This is a new field and combines pharmacology and genomics to develop effective and safe medications and doses that will be designed according to a person’s genetic organization. The field of pharmacogenomics is still in its early stage. Its use is currently quite limited, but new approaches are under study in clinical trials. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics and pharmacodynamics.

 

  • Genome
  • Drug response
  • Epigenetics
  • Genotyping
  • Genome sequencing
  • Polypharmacy
  • Drug labeling

Related Conference of Pharmacogenomics

July 27-28, 2026

19th World Drug Delivery Summit

Paris, France
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 14-15, 2026

6th International Conference on Pharmaceutical Chemistry

Paris, France
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
December 14-15, 2026

5th Global Summit on Pharmaceutical Research

Paris, France
January 26-27, 2027

22nd Annual Meet on Pharmaceutical Sciences

Paris, France
April 27-28, 2027

10th European Biopharma Congress

Paris, France

Pharmacogenomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in